thirteenda.htm -- Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________________________
SCHEDULE 13D/A
[Rule 13d-101]
                  
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO §240.13d-1(a) AND 
AMENDMENTS THERETO FILED PURSUANT TO §240.13d-2(a)
 
(Amendment No. 13)*
______________________________
Reinsurance Group of America, Incorporated
(Name of Issuer)
Common Stock, Par Value $0.01 Per Share
(Title of Class of Securities)
759351109
(CUSIP Number)
                        
______________________________
Gwenn L. Carr
MetLife, Inc.
1 MetLife Plaza
27-01 Queens Plaza North
Long Island City, New York 11101
(212) 578-2211
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
                           
______________________________
February 22, 2008
(Date of Event which Requires Filing of this Statement)
        If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this 
  Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box.    ¨
                       
      Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. 
See Rule 13d-7 for other parties to whom copies are to be sent.   
                            
_________________ 
    
    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for
any subsequent amendment containing information which would alter disclosures provided in a prior cover page. 
                      
      The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act 
of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). 


CUSIP No. 759351109                                         SCHEDULE 13D    (Page 2 of 8) 

 
1       NAMES OF REPORTING PERSONS     
       MetLife, Inc.             

2       CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP    (a)   ¨ 
                (b)   ¨ 

3       SEC USE ONLY         

4       SOURCE OF FUNDS     
       Not Applicable         

5       CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT 
       TO ITEM 2(d) or 2(e)     ¨

6       CITIZENSHIP OR PLACE OF ORGANIZATION     
       Delaware             

NUMBER OF 
  SHARES 
BENEFICIALLY 
OWNED BY 
EACH 
REPORTING 
PERSON WITH 
   

 

 

   
    
    
    
   

  7    SOLE VOTING POWER     
      None     
           
           
           
           
       
  8    SHARED VOTING POWER     
      32,243,539     

  9    SOLE DISPOSITIVE POWER     
      None     

  10    SHARED DISPOSITIVE POWER     
      32,243,539     

11       AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 
       32,243,539             

12       CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES     
       CERTAIN SHARES    (See Instructions)   ¨

13       PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)     
       52%*             

14       TYPE OF REPORTING PERSON  (See Instructions)    
       HC             

 
 *    This percentage is based upon 62,001,463 Shares issued and outstanding as of October 31, 2007, as reported in RGA’s Quarterly Report on
Form 10-Q for the quarterly period ended September 30, 2007.  
 
               

2


CUSIP No. 759351109                                         SCHEDULE 13D    (Page 3 of 8) 

1       NAMES OF REPORTING PERSONS     
       Metropolitan Life Insurance Company     

2       CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP    (a)   ¨ 
                (b)   ¨ 

3       SEC USE ONLY         

4       SOURCE OF FUNDS     
       Not Applicable         

5       CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT 
       TO ITEM 2(d) or 2(e)     ¨

6       CITIZENSHIP OR PLACE OF ORGANIZATION     
       New York             

NUMBER OF    7    SOLE VOTING POWER     
SHARES        None     
BENEFICIALLY             
OWNED BY             
EACH             
REPORTING             
PERSON WITH             

        8    SHARED VOTING POWER     
            32,243,539     

        9    SOLE DISPOSITIVE POWER     
            None     

        10    SHARED DISPOSITIVE POWER     
            32,243,539     

11       AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 
       32,243,539             

12       CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES     
       CERTAIN SHARES (See Instructions)  ¨ 

13       PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)     
       52%*             

14       TYPE OF REPORTING PERSON  (See Instructions)     
       IC             

 
*    This percentage is based upon 62,001,463 Shares issued and outstanding as of October 31, 2007, as reported in RGA’s Quarterly Report on
Form 10-Q for the quarterly period ended September 30, 2007.  
 
       

3


CUSIP No. 759351109                                         SCHEDULE 13D    (Page 4 of 8) 

 
1       NAMES OF REPORTING PERSONS     
       GenAmerica Financial, LLC     

2       CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP    (a) ¨
                (b) ¨ 

3       SEC USE ONLY         

4       SOURCE OF FUNDS     
       Not Applicable         

5       CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT 
       TO ITEM 2(d) or 2(e)       ¨

6       CITIZENSHIP OR PLACE OF ORGANIZATION     
       Missouri             

NUMBER OF 
SHARES 
BENEFICIALLY 
OWNED BY 
EACH 
REPORTING 
PERSON WITH  
  
   


 


    
    
    
   

  7    SOLE VOTING POWER     
      None     
           
           
           
           
       
  8    SHARED VOTING POWER     
      32,243,539     

  9    SOLE DISPOSITIVE POWER     
      None     

  10    SHARED DISPOSITIVE POWER     
      32,243,539     

11       AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 
       32,243,539             

12       CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES     
       CERTAIN SHARES   (See Instructions)                                                               ¨

13       PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)     
       52%*             

14       TYPE OF REPORTING PERSON (See Instructions)    
       HC, CO             

 
*    This percentage is based upon 62,001,463 Shares issued and outstanding as of October 31, 2007, as reported in RGA’s Quarterly Report on
Form 10-Q for the quarterly period ended September 30, 2007. 
 
               

4


CUSIP No. 759351109                                         SCHEDULE 13D    (Page 5 of 8) 

1       NAMES OF REPORTING PERSONS     
       General American Life Insurance Company     

2       CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP    (a)   ¨ 
                (b)   ¨ 

3       SEC USE ONLY         

4       SOURCE OF FUNDS     
       Not Applicable         

5       CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT 
       TO ITEM 2(d) or 2(e)         ¨

6       CITIZENSHIP OR PLACE OF ORGANIZATION     
       Missouri             

NUMBER OF    7    SOLE VOTING POWER     
SHARES        None     
BENEFICIALLY             
OWNED BY             
EACH             
REPORTING             
PERSON WITH             

        8    SHARED VOTING POWER     
            32,243,539     

        9    SOLE DISPOSITIVE POWER     
            None     

        10    SHARED DISPOSITIVE POWER     
            32,243,539     

11       AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 
       32,243,539             

12       CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES     
       CERTAIN SHARES  (See Instructions)     ¨

13       PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)     
       52%*             

14       TYPE OF REPORTING PERSON (See Instructions)    
       IC             

 
*    This percentage is based upon 62,001,463 Shares issued and outstanding as of October 31, 2007, as reported in RGA’s Quarterly Report on
Form 10-Q for the quarterly period ended September 30, 2007. 
 
               

5


     This Statement amends the Schedule 13D Statement, as amended, of (i) MetLife, Inc. (“MLINC”), (ii) Metropolitan Life Insurance Company, a wholly owned subsidiary of MLINC (“MetLife”), (iii) GenAmerica Financial, LLC, a wholly owned subsidiary of MetLife (“GenAm Financial”) and (iv) General American Life Insurance Company, a wholly owned subsidiary of GenAm Financial (“GenAm Life” and collectively with MLINC, MetLife and GenAm Financial, the “Filing Parties”), in respect of shares of common stock, par value $0.01 per share (“Shares”), of Reinsurance Group of America, Incorporated, a Missouri corporation (“RGA”), as follows:

ITEM 4.  PURPOSE OF TRANSACTION.

     Item 4 is hereby amended by replacing the final sentence of the third paragraph with the following:

     “On January 25, 2006, Lisa M. Weber resigned from her position on the Board of Directors of RGA. On January 26, 2006, Georgette A. Piligian was elected as a director of RGA. On January 18, 2007, Leland C. Launer, Jr. resigned from his position as chairman of the Board of Directors of RGA. On January 25, 2007, Steven A. Kandarian was elected as a director and as chairman of the Board of Directors of RGA.”

     Item 4 is hereby further amended by replacing the penultimate paragraph thereof with the following:

     “As previously disclosed, the Filing Parties continuously evaluate RGA’s businesses and prospects, alternative investment opportunities and other factors deemed relevant in determining whether additional Shares will be acquired by any of the Filing Parties or whether any of the Filing Parties will dispose of Shares. At any time, depending on certain factors including market conditions, trading prices for the Shares and of the securities of MLINC, actions taken by the Board of Directors of RGA, alternative investment opportunities and the outlook for RGA, the Filing Parties and other industry participants, one or more of the Filing Parties may acquire additional Shares or may dispose of some or all of the Shares beneficially owned by such Filing Parties, in either case in the open market, in privately negotiated transactions or otherwise. In this connection, the Filing Parties are examining certain alternatives for the disposition of all of the Shares held by the Filing Parties, including a tax-free exchange of all or substantially all of such Shares with MLINC securityholders and a sale of all or substantially all of such Shares to a third party. There is no assurance that the Filing Parties will determine to or agree with any other person to effect any transaction relating to the Shares or otherwise, nor as to the terms of any such transaction.”

ITEM 5.  INTEREST IN SECURITIES OF THE ISSUER.

     Item 5 is hereby amended by replacing the first sentence of the first paragraph of Item 5(a) and (b) with the following:

     “(a) and (b). As of February 22, 2008, each of the Filing Parties beneficially owned 32,243,539 Shares, or approximately 52 percent of the outstanding Shares.”

     Item 5 is hereby further amended by replacing the last paragraph of Item 5(a) and

6


(b) with the following:

     “The percentage amounts set forth in this Item 5 are based upon 62,001,463 Shares issued and outstanding as of October 31, 2007, as reported in RGA’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2007.”

     Item 5 is hereby further amended by removing the second paragraph of Item 5(a) and 5(b).

ITEM 6.  CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO THE SECURITIES OF THE ISSUER.

     Item 6 is hereby amended by removing the last paragraph of Item 6.

ITEM 7.  MATERIAL TO BE FILED AS EXHIBITS.

Exhibit    Description of Exhibits 

 
99.1    Directors and Executive Officers of the Filing Parties 
99.9    Agreement Required for Joint Filing Under Rule 13d-1(k)(1) 

 


 

7


    SIGNATURE

 After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

February 22, 2008

METLIFE, INC. 
 
By:    /s/ Joseph J. Prochaska, Jr.         
         Name: Joseph J. Prochaska, Jr. 
         Title: Executive Vice President and Chief Accounting Officer 
                 
METROPOLITAN LIFE INSURANCE COMPANY  
 
By:    /s/ Joseph J. Prochaska, Jr.         
         Name: Joseph J. Prochaska, Jr. 
         Title: Executive Vice President and Chief Accounting Officer  
                
GENAMERICA FINANCIAL, LLC 
 
By: Metropolitan Life Insurance Company, its Manager   
      
By:    /s/ Joseph J. Prochaska, Jr.         
         Name: Joseph J. Prochaska, Jr. 
         Title: Executive Vice President and Chief Accounting Officer 
 
GENERAL AMERICAN LIFE INSURANCE COMPANY 
 
By:    /s/ Joseph J. Prochaska, Jr.          
         Name: Joseph J. Prochaska, Jr. 
         Title: Executive Vice President and Chief Accounting Officer
                   

8


namesofdirectors.htm -- Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing

Exhibit 99.1

Directors and Executive Officers of the Filing Parties

Set forth below is the name and present principal occupation or employment of each director and executive officer of MLINC and MetLife. MLINC is a holding company and MetLife is an insurance company. The principal business address of MLINC and MetLife is 200 Park Avenue, New York, NY 10166-0188. Unless otherwise noted, the business address of each of the directors and executive officers is c/o MetLife, Inc. Each person listed below is a citizen of the United States.

Directors

Name and Business Address Principal Occupation or Employment
                  

Sylvia Mathews Burwell
The Bill and Melinda Gates Foundation
1551 Eastlake Avenue East
Seattle, Washington 98102

President of the Global Development Program at the Bill and Melinda Gates Foundation

            

Burton A. Dole, Jr.

Retired Chairman of Dole/Neal LLC (privately-held energy management firm), and retired Partner and Chief Executive Officer of MedSouth Therapy Associates, LLC (rehabilitative health care)
                  

Cheryl W. Grise

Retired Executive Vice President of Northeast Utilities (public utility holding company)

                  
C. Robert Henrikson

Chairman, President and Chief Executive Officer, MLINC and MetLife

               

James R. Houghton
Corning Incorporated 
80 E. Market Street 
Suite 201 
Corning, New York 14830

Chairman Emeritus and Director of Corning Incorporated (global technology)

                  

R. Glenn Hubbard
Dean’s Office
Columbia Business School
Uris Hall
3022 Broadway
New York, New York 10027

Dean of the Graduate School of Business at Columbia University (business school)
             
Helene L. Kaplan
Skadden, Arps, Slate, Meagher & Flom LLP
Four Times Square

New York, New York 10036
Of Counsel, Skadden, Arps, Slate, Meagher & Flom LLP (law firm)
             
John M. Keane
2020 K Street N.W.
Suite 300
Washington, DC 20006

Co-Founder and Senior Managing Director of Keane Advisors, LLC (private equity investment firm)



Name and Business Address Principal Occupation or Employment
                  

James M. Kilts
Centerview Partners Management, LLC
16 School St.
Rye, NY 10580

Partner, Centerview Partners Management, LLC (financial advisory firm)

                

Charles M. Leighton
US SAILING
15 Maritime Drive
Portsmouth, Rhode Island 02871

Executive Director of US SAILING

 

                 

Hugh B. Price
Brookings Institution
1775 Massachusetts Avenue, NW
Washington, D.C. 20036

 Senior Fellow, Brookings Institution
              

David Satcher
Morehouse School of Medicine
720 Westview Drive SW
Atlanta, Georgia 30310-1495

Director of the Satcher Health Leadership Institute and the Center of Excellence on Health Disparities at the Morehouse School of Medicine
                

Kenton J. Sicchitano

Retired Global Managing Partner of PricewaterhouseCoopers, LLP (assurance, tax and advisory services)

 
                 

William C. Steere, Jr.
Pfizer Inc.
235 East 42nd Street, 22nd Floor
New York, New York 10017

Retired Chairman of the Board and Chief Executive Officer of Pfizer Inc.


2


 Executive Officers (who are not directors)
                               
Name                                                                 Principal Occupation or Employment 
                                                     
Ruth A. Fattori  Executive Vice President and Chief Administrative Officer, MLINC and MetLife   
                                                                                

Steven A. Kandarian

Executive Vice President and Chief Investment Officer, MLINC and MetLife

  

James L. Lipscomb

Executive Vice President and General Counsel, MLINC and MetLife

                

Maria R. Morris

Executive Vice President, Technology and Operations, MLINC and MetLife

                

William J. Mullaney

President, Institutional Business, MLINC and MetLife

  

Catherine A. Rein

Senior Executive Vice President, MLINC and MetLife

  

William J. Toppeta      

President, International, MLINC and MetLife

  
Lisa M. Weber President, Individual Business, MLINC and MetLife                                
           

William J. Wheeler

Executive Vice President and Chief Financial Officer, MLINC and MetLife


GenAm Financial is a holding company. The principal business address of GenAm Financial is One MetLife Plaza, 27-01 Queens Plaza North, Long Island City, New York 11101. GenAm Financial is a limited liability company with MetLife serving as its Manager. The directors and executive officers of MetLife are listed above.

3


Set forth below is the name and present principal occupation or employment of each director and executive officer of GenAm Life. GenAm Life is an insurance company. The principal business address of GenAm Life is 13045 Tesson Ferry Road, St. Louis, Missouri 63128. Unless otherwise noted, the business address for each of the directors and executive officers is c/o MetLife, Inc. Each person listed below is a citizen of the United States.

Name and Business Address Principal Occupation or Employment
 

Mark K. Farrell
10 Park Avenue
Morristown, New Jersey 07962

Senior Vice President, MetLife; Director, GenAm Life

  

James L. Lipscomb 

Executive Vice President and General Counsel, MLINC and MetLife; Director, GenAm Life

   

William J. Mullaney

President, Institutional Business, MLINC and MetLife; Director, GenAm Life

  

Joseph J. Prochaska, Jr.

Executive Vice President and Chief Accounting Officer, MLINC, MetLife and GenAm Life

  

Catherine A. Rein

Senior Executive Vice President, MLINC and MetLife; Director, GenAm Life

 

Eric T. Steigerwalt

Senior Vice President and Treasurer, MLINC, MetLife and GenAm Life; Director, GenAm Life

 

Stanley J. Talbi

Executive Vice President, MetLife; Director, GenAm Life

             
Michael J. Vietri Director, GenAm Life 
             

Lisa M. Weber

President, Individual Business, MLINC and MetLife; Chairman of the Board, President, Chief Executive Officer and Director, GenAm Life

 

William J. Wheeler

Executive Vice President and Chief Financial Officer, MLINC and MetLife; Director, GenAm Life


4


exhibit991.htm -- Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing

Exhibit 99.9

Joint Filing Agreement

In accordance with Rule 13d-1(k)(1) of Regulation 13D-G of the Securities Exchange Act of 1934, the persons or entities below agree to the joint filing on behalf of each of them of the Statement on Schedule 13D (including any and all amendments thereto) with respect to the Common Stock of Reinsurance Group of America, Incorporated, and agree that such statement is, and any amendments thereto filed by any of them will be, filed on behalf of each of them, and further agree that this Joint Filing Agreement be included as an Exhibit to such joint filings.

Dated: February 22, 2008

METLIFE, INC. 
 
By:    /s/ Joseph J. Prochaska, Jr.        
         Name: Joseph J. Prochaska, Jr.
            Title: Executive Vice President and Chief Accounting Officer
 
METROPOLITAN LIFE INSURANCE COMPANY 
 
By:    /s/ Joseph J. Prochaska, Jr.        
         Name:  Joseph J. Prochaska, Jr.
            Title:  Executive Vice President and Chief Accounting Officer
         
GENAMERICA FINANCIAL, LLC 
 
By: Metropolitan Life Insurance Company, its Manager 
 
By:    /s/ Joseph J. Prochaska, Jr.        
         Name:  Joseph J. Prochaska, Jr.
            Title:  Executive Vice President and Chief Accounting Officer 
 
 
GENERAL AMERICAN LIFE INSURANCE COMPANY   
 
By:    /s/ Joseph J. Prochaska, Jr.        

            Name:  Joseph J. Prochaska, Jr.
            Title:  Executive Vice President and Chief Accounting Officer